List of insiders holdings for CRISPR Therapeutics AG:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | GLAXOSMITHKLINE PLC 10% Owner | 2020-07-10 17:26:33 | 3,310,627 0 | 3,310,627 | Form 13D |
| 2 | BAYER AKTIENGESELLSCHAFT Bayer Global Investments B.V. 10% Owner | 2020-02-04 16:19:06 | 2,954,775 0 | 2,954,775 | Form 13D |
| 3 | CELGENE CORP 10% Owner | 2018-02-08 16:25:56 | 2,800,772 0 | 2,800,772 | Form 13D |
| 4 | Vertex Pharmaceuticals (Europe) Ltd VERTEX PHARMACEUTICALS INC 10% Owner | 2020-02-13 16:05:28 | 2,690,470 0 | 2,690,470 | Form 13G |
| 5 | Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP Versant Ventures IV LLC Versant Ventures V LLC Versant Ventures V (Canada) L.P. 10% Owner | 2021-02-16 07:33:52 | 1,344,010 0 | 1,344,010 | Form 13D |
| 6 | Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Ventures IV LLC Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP 10% Owner | 2021-02-16 07:33:52 | 1,344,010 0 | 1,344,010 | Form 13D |
| 7 | EMSTER KURT VON Director | 2019-01-18 16:32:23 | 0 1,171,268 | 1,171,268 | Form 4/A |
| 8 | Lundberg Sven Ante Chief Scientific Officer | 2017-02-10 14:16:28 | 505,217 505,617 | 1,010,834 | Form 4 |
| 9 | Hadley Harbor Master Investors (Cayman) L.P. 10% Owner | 2016-10-24 14:58:09 | 744,380 0 | 744,380 | Form 4 |
| 10 | Novak Rodger President | 2021-07-01 17:43:55 | 573,007 0 | 573,007 | Form 4 |
| 11 | Kulkarni Samarth Chief Executive Officer | 2026-03-24 17:37:54 | 491,000 0 | 491,000 | Form 4 |
| 12 | TOMSICEK MICHAEL JOHN Chief Financial Officer | 2021-08-10 20:00:31 | 132,891 0 | 132,891 | Form 4 |
| 13 | Versant Venture Capital V L.P. Versant Ventures V LLC Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP 10% Owner | 2018-04-26 16:44:03 | 0 115,645 | 115,645 | Form 4 |
| 14 | Subramanian Kala See Remarks | 2017-06-19 16:05:33 | 85,000 0 | 85,000 | Form 4 |
| 15 | Dylan-Hyde Tyler Chief Legal Officer | 2018-01-18 17:38:36 | 67,104 0 | 67,104 | Form 4 |
| 16 | Ho Tony W Executive VP, Head of R&D | 2021-12-07 20:00:19 | 65,697 0 | 65,697 | Form 4 |
| 17 | CAGNONI PABLO J Director | 2019-11-21 16:07:43 | 63,833 0 | 63,833 | Form 4 |
| 18 | Woiwode Thomas Director | 2018-06-15 21:39:45 | 0 30,000 | 30,000 | Form 4 |
| 19 | Bruno Julianne Chief Operating Officer | 2025-03-24 17:35:07 | 21,794 7,088 | 28,882 | Form 4 |
| 20 | Patel Naimish Chief Medical Officer | 2026-06-02 17:41:55 | 22,000 0 | 22,000 | Form 4 |
| 21 | Prasad Raju Chief Financial Officer | 2026-06-02 17:41:26 | 19,500 0 | 19,500 | Form 4 |
| 22 | KASINGER JAMES R. General Counsel and Secretary | 2026-06-02 17:42:26 | 17,000 0 | 17,000 | Form 4 |
| 23 | Morrow Phuong Khanh Chief Medical Officer | 2023-10-17 17:52:27 | 16,667 0 | 16,667 | Form 4 |
| 24 | Smith Brendan Chief Financial Officer | 2023-02-22 17:41:41 | 16,547 0 | 16,547 | Form 4 |
| 25 | COLES N ANTHONY Director | 2017-06-02 16:30:19 | 15,000 0 | 15,000 | Form 4 |
| 26 | Behbahani Ali Director | 2026-06-09 18:06:29 | 13,000 0 | 13,000 | Form 4 |
| 27 | George Simeon Director | 2026-06-09 18:09:19 | 13,000 0 | 13,000 | Form 4 |
| 28 | Fardis Maria Director | 2026-06-09 17:43:39 | 13,000 0 | 13,000 | Form 4 |
| 29 | Fleming Harold Edward Director | 2026-06-09 17:43:22 | 13,000 0 | 13,000 | Form 4 |
| 30 | Greene John Director | 2026-06-09 17:43:01 | 13,000 0 | 13,000 | Form 4 |
| 31 | High Katherine A Director | 2026-06-09 17:42:32 | 13,000 0 | 13,000 | Form 4 |
| 32 | Mahatme Sandesh Director | 2026-06-09 17:42:05 | 13,000 0 | 13,000 | Form 4 |
| 33 | Morrison Briggs Director | 2026-06-09 17:41:28 | 13,000 0 | 13,000 | Form 4 |
| 34 | Rommel Christian Director | 2026-06-09 17:41:00 | 13,000 0 | 13,000 | Form 4 |
| 35 | Treco Douglas A Director | 2026-06-09 17:40:32 | 13,000 0 | 13,000 | Form 4 |
| 36 | Klein Lawrence Otto CBO & COO | 2022-08-18 17:36:02 | 12,500 0 | 12,500 | Form 4 |
| 37 | Bolzon Bradley J PhD Director | 2022-06-10 17:35:09 | 12,000 0 | 12,000 | Form 4 |